Have a personal or library account? Click to login
Mesothelioma Diagnosis: A Comprehensive Guideline-based Approach Cover

Mesothelioma Diagnosis: A Comprehensive Guideline-based Approach

Open Access
|May 2024

References

  1. Berzenji L, Van Schil PE, Carp L. The eighth TNM classification for malignant pleural mesothelioma. <em>Transl Lung Cancer Res</em>. 2018;7(5). doi:<a href="https://doi.org/10.21037/tlcr.2018.07.05" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.21037/tlcr.2018.07.05</a>
  2. Woolhouse I, Bishop L, Darlison L, et al. BTS guideline for the investigation and management of malignant pleural mesothelioma. <em>BMJ Open Respir Res</em>. 2018;5(1). doi:<a href="https://doi.org/10.1136/bmjresp-2017-000266" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1136/bmjresp-2017-000266</a>
  3. Popat S, Baas P, Faivre-Finn C, et al. Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. <em>Annals of Oncology</em>. 2022;33(2). doi:<a href="https://doi.org/10.1016/j.annonc.2021.11.005" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/j.annonc.2021.11.005</a>
  4. Scherpereel A, Scherpereel A, Opitz I, et al. ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma. <em>European Respiratory Journal</em>. 2020;55(6). doi:<a href="https://doi.org/10.1183/13993003.00953-2019" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1183/13993003.00953-2019</a>
  5. Barbieri PG, Somigliana A, Girelli R, Lombardi S, Sarnico M, Silvestri S. [Pleural mesothelioma in a school teacher: asbestos exposure due to DAS paste]. <em>Med Lav</em>. 2016;107(2).
  6. Messina G, Bove M, Natale G, et al. Diagnosis of malignant pleural disease: Ultrasound as “a detective probe.” <em>Thorac Cancer</em>. 2023;14(3). doi:<a href="https://doi.org/10.1111/1759-7714.14735" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1111/1759-7714.14735</a>
  7. Sinha S, Swift AJ, Kamil MA, et al. The role of imaging in malignant pleural mesothelioma: an update after the 2018 BTS guidelines. <em>Clin Radiol</em>. 2020;75(6). doi:<a href="https://doi.org/10.1016/j.crad.2019.12.001" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/j.crad.2019.12.001</a>
  8. Shiroshita A, Kurosaki M, Takeshita M, Kataoka Y. Medical thoracoscopy, computed tomography-guided biopsy, and ultrasound-guided biopsy for malignant pleural mesothelioma: A systematic review. <em>Anticancer Res</em>. 2021;41(5). doi:<a href="https://doi.org/10.21873/ANTICANRES.14998" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.21873/ANTICANRES.14998</a>
  9. Friedberg JS, Culligan MJ, Tsao AS, et al. A Proposed System Toward Standardizing Surgical-Based Treatments for Malignant Pleural Mesothelioma, From the Joint National Cancer Institute–International Association for the Study of Lung Cancer–Mesothelioma Applied Research Foundation Taskforce. <em>Journal of Thoracic Oncology</em>. 2019;14(8). doi:<a href="https://doi.org/10.1016/j.jtho.2019.04.029" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/j.jtho.2019.04.029</a>
  10. Michael CW, Bedrossian CCWM, Sadri N, Klebe S. The cytological features of effusions with mesothelioma in situ: A report of 9 cases. <em>Diagn Cytopathol</em>. Published online 2023. doi:<a href="https://doi.org/10.1002/dc.25129" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1002/dc.25129</a>
  11. Courtiol P, Maussion C, Moarii M, et al. Deep learning-based classification of mesothelioma improves prediction of patient outcome. <em>Nat Med</em>. 2019;25(10). doi:<a href="https://doi.org/10.1038/s41591-019-" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1038/s41591-019-</a> 0583-3
  12. Borgeaud M, Kim F, Friedlaender A, Lococo F, Addeo A, Minervini F. The Evolving Role of Immune-Checkpoint Inhibitors in Malignant Pleural Mesothelioma. <em>J Clin Med</em>. 2023;12(5). doi:<a href="https://doi.org/10.3390/jcm12051757" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.3390/jcm12051757</a>
DOI: https://doi.org/10.2478/pneum-2023-0036 | Journal eISSN: 2247-059X | Journal ISSN: 2067-2993
Language: English
Page range: 137 - 140
Published on: May 2, 2024
Published by: Romanian Society of Pneumology
In partnership with: Paradigm Publishing Services
Publication frequency: 1 times per year

© 2024 Tudor P. Toma, published by Romanian Society of Pneumology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.